Peer Review reports
From: Sigma-2 receptor/TMEM97 agonist PB221 as an alternative drug for brain tumor
| Original Submission | ||
|---|---|---|
| 9 Nov 2018 | Submitted | Original manuscript |
| 25 Dec 2018 | Reviewed | Reviewer Report - Wen-Wei Chang |
| 26 Dec 2018 | Reviewed | Reviewer Report - Jian Chen |
| 28 Feb 2019 | Author responded | Author comments - Chia-Chi Liu |
| Resubmission - Version 2 | ||
| 28 Feb 2019 | Submitted | Manuscript version 2 |
| 10 Apr 2019 | Reviewed | Reviewer Report - Wen-Wei Chang |
| 7 May 2019 | Author responded | Author comments - Chia-Chi Liu |
| Resubmission - Version 3 | ||
| 7 May 2019 | Submitted | Manuscript version 3 |
| Publishing | ||
| 10 May 2019 | Editorially accepted | |
| 20 May 2019 | Article published | 10.1186/s12885-019-5700-7 |
You can find further information about peer review here.